Tag Archives: Obama

Obama Budget Takes Slap at Pharma

Despite a slight boost in funding for the Food and Drug Administration and stronger tax incentives for investment in R&D, significant changes in Medicare drug reimbursement and coverage policies have biopharmaceutical companies up in arms.
Posted in Biotech, IP, Legal, R&D, Regulatory | Also tagged , , | Leave a comment

Part D Politics: Medicare Drug Rebates or Price Controls?

Jill Wechsler Blog – PE Feb. 22, 2013 Part D Politics:  Medicare drug rebates or price controls? While health care was barely mentioned in the recent State of the Union address, President Obama generated some interest in his proposal to cut Medicare spending by reducing “taxpayer subsidies to prescription drug companies.” That’s code for requiring […]
Posted in healthcare, Op-Ed, pricing, Regulatory | Also tagged , , , | Leave a comment

Governor Howard Dean: Financing the Future of US Drug Innovation

Will it be More Good Pills — Or that Porsche? The Obama Administration’s signal achievement to date — passage of comprehensive health reform legislation — continues to inspire confusion and contradictions across the political spectrum. Despite its scope, the bill is dismissed by many Democrats for what it does not do, while the GOP references […]
Posted in FDA, healthcare, R&D, Regulatory | Also tagged , , , , | 1 Comment

Daschle Ditches HHS Nomination

In light of the controversy surrounding his tax records, Tom Daschle withdrew his nomination for Secretary of Health and Human Services (HHS) Tuesday. But by throwing Daschle’s nod out the window, it could drag any hope for healthcare reform in 2009 with it. Daschle seemed like a shoe in for the HHS position from the […]
Posted in People | Also tagged , , , | Leave a comment
  • Categories

  • Meta